Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formato: Artigo
Lenguaje:Russo
Publicado: «FIRMA «SILICEA» LLC 2004-12-01
Colección:Российский кардиологический журнал
Materias:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Acceso en línea:https://russjcardiol.elpub.ru/jour/article/view/2326
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares